FBB Biomed
Iowa City, US · Founded 2019 · Delaware corporation · 1 known investors
Find your way into FBB Biomed
83 people in our graph share verified history with the FBB Biomed team — schools, employers, funds. One of them is your warm intro.
Gary Kushnerunlockedknows Howard Urnovitz · together at University of Michigan (overlapped)
knows the team · via University of Michigan
×4knows the team · via University of Iowa
×6knows the team · via Washington University School of Medicine
FBB Biomed builds an analytics platform that uses blood RNA-seq data to quantify gene activity across the biological systems involved in a patient's chronic disease. It serves diagnostic labs offering RNA-based monitoring tests and biopharma companies stratifying trial participants and measuring individual treatment response.
Founders & leadership
FBB Biomed was founded in 2019 by Howard Urnovitz.
HU
Howard UrnovitzinFounder · Chief Executive OfficerHoward Urnovitz spent his career in virology, molecular diagnostics, and immunology, with early work on non-coding DNA regions. He is founder of FBB Biomed, which develops an RNA-based analytics platform for diagnostic labs and biopharma companies to detect disease and measure treatment response from blood samples.
Investors · 1
Reported raises · per SEC filings
Form D private placements$511K disclosed across 4 of 5 rounds · 2019–2024
▶$326KraisedAug 2020 · 6 investors · BiotechnologyRule 506(b)
▶$326KraisedAug 2020 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Howard Bruce UrnovitzExecutive Officer, Director
- Offering amount
- $500K
- Amount sold
- $326K
- Minimum investment
- $10K
- Proceeds to insiders
- $70K
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$75KraisedMar 2020 · 4 investors · BiotechnologyRule 506(b)
▶$75KraisedMar 2020 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Howard Bruce UrnovitzExecutive Officer, Director
- Offering amount
- $105K
- Amount sold
- $75K
- Minimum investment
- $10K
- Proceeds to insiders
- $20K
- First sale
- Jan 2020
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$77.5KraisedDec 2019 · 16 investors · BiotechnologyRule 506(b)
▶$77.5KraisedDec 2019 · 16 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Howard Bruce UrnovitzExecutive Officer, Director
- Offering amount
- $77.5K
- Amount sold
- $77.5K
- Minimum investment
- $150
- Proceeds to insiders
- $10K
- First sale
- Dec 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
▶$32.5KraisedDec 2019 · 3 investors · BiotechnologyRule 506(b)
▶$32.5KraisedDec 2019 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Howard Bruce UrnovitzExecutive Officer, Director
- Offering amount
- $32.5K
- Amount sold
- $32.5K
- Minimum investment
- $2K
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does FBB Biomed do?
- FBB Biomed builds an analytics platform that uses blood RNA-seq data to quantify gene activity across the biological systems involved in a patient's chronic disease. It serves diagnostic labs offering RNA-based monitoring tests and biopharma companies stratifying trial participants and measuring individual treatment response.
- Who founded FBB Biomed?
- FBB Biomed was founded by Howard Urnovitz in 2019.
- Who are FBB Biomed's investors?
- FBB Biomed's investors include Loyal VC.
- How much funding has FBB Biomed raised?
- FBB Biomed has disclosed $511K raised across 4 of its 5 known rounds.
- Where is FBB Biomed headquartered?
- FBB Biomed is headquartered in Iowa City, US.